Cite
HARVARD Citation
Llibre, J. et al. (2019). Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort2. HIV medicine. 20 (3), pp. 237-247. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Llibre, J. et al. (2019). Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort2. HIV medicine. 20 (3), pp. 237-247. [Online].